Screener
IDEAYA Biosciences, Inc. IDYA Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206357
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Loss from operations | (108,544) | (84,389) |
| Other income | ||
| Interest income and other income, net | 10,005 | 12,211 |
| Net loss | $(98,539) | $(72,178) |
| Unrealized (losses) gains on marketable securities | (2,761) | 773 |
| Comprehensive loss | $(101,300) | $(71,405) |
| Net loss per common share, basic and diluted | $(1.11) | $(0.82) |
| Weighted-average common shares outstanding, basic and diluted | 88,699,754 | 88,356,335 |
Item 1. Financial Statements (UNAUDITED).
FAQ
- What is IDEAYA Biosciences, Inc.'s net income?
- IDEAYA Biosciences, Inc. (IDYA) reported net income of -$98.54M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s net income changed year-over-year?
- IDEAYA Biosciences, Inc.'s net income decreased by 36.5% year-over-year, from -$72.18M to -$98.54M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s net income?
- Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s net income has grown at a 22.9% compound annual growth rate (CAGR), from -$49.76M to -$113.7M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about IDEAYA Biosciences, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude